Photobiomodulation
Photobiomodulation is the use of light to influence cellular function, also known as low level light therapy.
How does the Arunalight work?
The Arunalight looks like a pair of sunglasses and is worn for 3 minutes every other day at home. A total of 26 red lights are strategically placed to gently treat the eyes and surrounding skin. With a lifespan for thousands of uses, these medical grade light diodes offer a superior defined and optimized wavelength (670nm).
What is the Arunalight used for?
Photobiomodulation has shown great promise in treating various retinal conditions. A study by Behlahbib et al. (2023) suggests that photobiomodulation may offer a viable therapeutic option for age-related macular degeneration, potentially slowing the progression of the disease. Additionally, another study demonstrated a significant reduction in the onset of new geographic atrophy in patients receiving photobiomodulation treatment.
Additional studies show promising results for photobiomodulation in treating diabetic retinopathy, including reducing macular edema and improving visual acuity. In glaucoma, PBM may help enhance retinal nerve fiber layer thickness and lower intraocular pressure. For dry eye syndrome, it has the potential to increase tear production and improve meibomian gland function. PBM also shows promise in reducing inflammation in uveitis and other inflammatory ocular conditions. While most studies to date have been conducted in animal models, the findings are promising, and while applications to humans are still limited, they remain a potential avenue for future exploration.
Some studies involving Cellular Mechanisms activated with Photobiomodulation at 670nm
Introducing the Arunalight!
An advanced red light eye therapy to improve blood flow and stimulate cellular energy in only 3 minutes!
What is Photobiomodulation?
Photobiomodulation is a form of light therapy that uses red light to stimulate mitochondria in our cells. Mitochondria, often called the "powerhouses" of the cell, are responsible for energy production. They contain chromophores, which are molecules that absorb specific wavelengths of light. When red and near-infrared light is applied, these chromophores absorb the light, helping the mitochondria break down nutrients and convert them into ATP (adenosine triphosphate), the primary energy currency of our cells.
"Modulating" means to adjust or control something. In this context, it refers to enhancing how mitochondria function and how much energy they produce. Research shows that specific wavelengths of red and near-infrared light can boost ATP production, leading to increased energy transport within cells and promoting cellular proliferation—the process by which cells grow and divide.
Using red light on mitochondria is analogous to giving them a boost or a tune-up, helping them work more efficiently. This therapy can be beneficial for healing, reducing inflammation, and improving overall cell health.
Findings in vitro and in vivo support the hypothesis that photobiomodulation (PBM) enhances mitochondrial function and activates antioxidant pathways in the neural retina, protecting against retinal degeneration. PBM offers a non-invasive alternative to traditional treatments, harnessing the body's natural repair mechanisms to prevent and treat retinal dystrophies and degenerative diseases.
Recent data indicate that 670nm red light significantly protects the retina from light-induced damage, suggesting its potential to mitigate the harmful effects of bright light exposure. This non-invasive approach shows promise for treating retinal degenerative disorders and ocular inflammatory diseases.
The effectiveness of PBM depends on factors such as light source, wavelength, energy density, light pulse structure, and application duration.